Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study. (gut.bmj.com)

Authors: Xiang YJ … Cheng SQ Journal: Gut Published: 2026-07-03 DOI: https://doi.org/10.1136/gutjnl-2026-338462